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Placenta as a source of hematopoietic stem cells
Elaine Dzierzak and Catherine Robin
Erasmus MC Stem Cell Institute, Dept of Cell Biology, Erasmus University Medical Center
Rotterdam, Netherlands
Abstract
The placenta is a large, highly vascularized hematopoietic tissue that functions during embryonic
and foetal development of eutherian mammals. Although recognized as the interface tissue
important in the exchange of oxygen, nutrients and waste products between the foetus and mother,
the placenta has increasingly become a focus of research concerning the ontogeny of the blood
system. Here, we describe recent data showing the intrinsic hematopoietic potential and
appearance of hematopoietic cells in the mouse and human placenta, and probe the biological
rationale behind its hematopoietic function. As a rest tissue that contains potent hematopoietic
stem cells, the human placenta could represent (in addition to umbilical cord blood cells) an
accessible supplemental source of cells for therapeutic strategies.
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Early placenta development
The placenta is a mysterious tissue that has been known since the earliest times as the “alter
ego” or “external soul” of the foetus. Aristotle recognized it as a tissue from which the
embryo receives its nourishment, and Leonardo da Vinci and Vesalius depicted it as a disc at
the maternal-foetal interface in the uterus 1. It was only in the mid-1500s that it gained its
name placenta (from Latin), meaning flat cake. Proposed to be the liver and lungs of the
foetus, only in 1734 was it established that the foetal and maternal vasculature of the
placenta were not continuous 2. Although this aspect of placental anatomy remained
controversial for many years (awaiting improved microscopic techniques and molecular
markers), the function of the placenta was accepted to be facilitation of nutrient and waste
exchange between the mother and foetus, provision of immunoprotection for the foetus and
production of factors and hormones for foetal growth 3.
The development of the placenta has been extensively studied in the mouse conceptus 4. At
embryonic day (E) 8.5, the allantois, a mesodermal outgrowth from the posterior end of the
embryo, contacts the chorionic epithelium in the extraembryonic part of the conceptus
(Figure 1A). This event is called chorio-allantoic fusion. Thereafter, a network of
vasculature is generated from the allantois and grows into the chorionic plate. These vessels
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undergo extensive branching. The endothelial cells lining these vessels are in direct
apposition with syncytiotrophoblasts and it is in the small spaces surrounding these
structures that the maternal blood bathes the foetal villi. A diagram of the anatomical
structure of the mouse placenta is provided in Figure 1B. Instead of the compact, maze-like
villi in the labyrinth layer found in the mouse, the villous structures in the human placenta
are less branched and the intervillous space is more open. Placenta architecture varies
between species, but there are general similarities across evolution that include placental cell
types, functions, and gene and protein expression reflecting developmental and regulatory
conservation 5, 6.
The placenta is connected to the embryo through the umbilical cord. The umbilical artery is
contiguous with the dorsal aorta, the main artery of the embryo (Figure 2A). Initially the
connection is at the caudal aspect of the dorsal aorta, but following vascular remodelling, the
connection becomes abdominal 7. Blood circulation throughout the embryo and
extraembryonic tissue is established at E8.25 in the mouse (Figure 2B) and beginning
between weeks 3 and 4 of gestation in the human conceptus. Following the development and
growth of the placenta at these early stages, maternal circulation flows through the
intervillous spaces beginning at approximately E10.5 and about the 11th week of gestation in
the mouse and human placentas, respectively 8. It is at this time that the placenta becomes
functional in its role as the exchange chamber between mother and foetus.
The placenta and hematopoiesis
As compared to its generally recognized functions, the appreciation of the placenta as a
potent hematopoietic site is relatively recent. Hematopoietic activity was initially observed
in the mouse placenta in the 1960s and 1970s, but these findings were not immediately
pursued (reviewed in 9). Studies in human placental villi suggest that already at day 21
postconception, macrophage-like cells and hemangioblastic cords arise from mesenchymal
cells 10. Tissue grafting studies in the avian embryo model by Dieterlen-Lievre reveal that
cells derived from the avian allantois contribute to adult haematopoiesis 11. Subsequent
studies by this group established that the mouse placenta harbours a wide range of
clonogenic hematopoietic progenitors beginning around E9 12. Although this is slightly later
than the time such cells appear in the embryo proper or the yolk sac (Figure 2B), the
placenta contains the most progenitors of any site up until E12 when the foetal liver
surpasses it. The continued presence of hematopoietic progenitors in the mouse placenta
throughout gestation demonstrates that the placenta it is a highly potent hematopoietic site.
Hematopoietic stem cells (HSCs) are found in highly vascularized tissues including the
mouse placenta (reviewed in 13-15). HSCs are the basis of the adult hematopoietic hierarchy
that produces all the blood lineages throughout adult life. Putative HSCs are tested by the
stringent transplantation assay in which the donor cells are challenged to provide complete,
long-term hematopoietic repopulation of adult irradiated (HSC-depleted) normal recipients.
Using allelic or transgene markers to distinguish foetal-derived cells, HSCs are detectable in
the mouse placenta at early E11 and HSC numbers increase dramatically up to E12.5 16, 17.
Thereafter, HSC numbers in the placenta are superseded by the fetal liver, and after E15.5,
very few or no HSCs are found in the placenta 16. Placenta HSCs express many of the same
surface marker proteins as adult bone marrow and foetal liver HSCs, including CD34 and c-
kit 16. Also, all placental HSCs express Ly6A (Sca-1) GFP (Stem cell antigen-1, green
fluorescent protein) 17. Interestingly, Ly6A GFP expressing cells localize within the
vasculature of the placental labyrinth and the umbilical vessel, and most of these cells
express CD34. Histologic analyses show that the midgestation mouse placenta expresses
important hematopoietic transcription factors such as Gata-2, Gata-3 and Runx1 17. Gata-2
is expressed in some endothelial cells and cells surrounding the vessels within the labyrinth,
Dzierzak and Robin Page 2
Trends Mol Med. Author manuscript; available in PMC 2013 March 02.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
whereas Gata-3 is restricted to a few cells at the maternal-foetal interface. Runx1 is
expressed in cells within the vascular lumen and the endothelium as well as cells
surrounding the vasculature of the labyrinth 17, 18. The patterns of Gata-2 and Runx1
expression strongly suggest HSCs and progenitors are localized within the labyrinth and
near the chorionic plate.
Human placenta hematopoiesis
Throughout development, the human placenta similarly contains a wide variety of
hematopoietic cells, as well as mature and immature hematopoietic progenitors and HSCs
(Figure 3). Primitive erythroblasts that morphologically resemble those in the yolk sac fill
the placental vessels beginning around day 24 19. These cells express glycophorin-A,
GATA-2 and c-KIT, but are not positive for CD34 or CD45. As measured by in vitro
colonogenic activity, mature and immature hematopoietic progenitors are found as early as
week 6 in gestation through week 17, and at term 20-23. These progenitors are multipotent
and produce erythroid and myeloid lineage cells, including granulocytes and macrophages.
The progenitors are initially in both CD34- and CD34+ fractions, but by week 15, all
progenitors are CD34+ 20-22. Leukocytes begin to express CD45 at 12-14 weeks in gestation
and at term.
As a hematopoietic territory, the appearance of hematopoietic cells in the early gestational
stage human placenta is slightly delayed as compared to the other hematopoietic sites
(Figure 3). The human yolk sac begins generating blood at day 16 with the production of
primitive erythroid cells, and at day 19, the intra-embryonic splanchnopleura (aorta region)
becomes hematopoietic. The emergence of multipotent progenitors, HSCs and clusters of
cells closely adherent to the ventral wall of the dorsal aorta, starts at around day 27 in the
developing splanchnopleura/aorta-gonad-mesonephros (AGM) region 24. Beginning at day
30 and week 13, the first erythroid progenitors and multilineage progenitors respectively,
colonize the liver. Thereafter, the bone marrow becomes hematopoietic 25. Thus, sequential
waves of hematopoietic activity in the human conceptus and placenta are similar to those in
the mouse conceptus.
Using the NOD-SCID (non-obese diabetic-severe combined immunodeficient) mouse
transplantation assay (the surrogate transplantation assay for human HSC identification),
potent multilineage, high-level repopulating HSCs have been found in the human
placenta 22. Donor human placental cells contribute to high percentages of B lymphocytes
and myeloid cells in the bone marrow and spleen of NOD-SCID recipients 10 weeks
postinjection. HSCs can be found in the human placenta beginning at week 6 of gestation,
throughout trimesters 1 and 2, and at the time of delivery (term). Considering the almost
total absence of HSCs in the mouse term placenta 16, the discovery of HSCs in the human
term placenta was unexpected. Human placental HSCs were verified as being foetal-derived
by human forensic identity PCR analysis, indicating that the human placenta still functions
to maintain, expand and/or produce the most immature of foetus-derived hematopoietic
cells 22.
Interestingly, cell extraction methods allowing the isolation of cells from the placenta
vasculature reveal that many potent HSCs are either closely adherent to the endothelium or
are within the niches of this compartment 22. At week 6 in gestation, HSCs are found both in
the CD34+ and CD34- fractions. It is as yet uncertain whether at later stages of development,
placenta HSCs are retained in both these fractions, as they are in umbilical cord blood 26, 27.
If so, the vascular endothelium might be either considered as the cellular source of HSCs or
provide an important HSC growth supportive microenvironment.
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Microenvironment of the placenta
Hematopoietic tissues harbour hematopoietic progenitors and stem cells in specific
microenvironments or niches 28. Studies of adult bone marrow show that the
microenvironment is a complex structure composed of mesenchymal stromal cells,
endothelial cells, osteoblasts, adipocytes, extracellular matrix, growth factors, cytokines and
adhesive molecules that provide support and regulatory functions for hematopoietic
progenitor or stem-cell homing, self renewal, maintenance and differentiation. A close
relationship exists between HSCs and the endosteal and endothelial niches in the bone
marrow 29, 30. The hematopoietic niche of the placenta within the labyrinth is likely to be
similar, consisting of endothelial, perivascular and mesenchymal cells but also placenta-
specific syncytiotrophoblast cells.
Interestingly, throughout mouse development, the temporal and spatial distribution of
mesenchymal stromal cells (MSC) correlates with hematopoietic territories such as the
AGM, foetal liver and neonatal bone marrow 31. MSC lines have been derived from these
tissues and many of these cell lines can provide support for hematopoietic cells in
vitro 32, 33, underlining the role that stromal cells play in the proliferation and/or survival of
HSCs. Such MSCs have osteogenic, adipogenic, chondrogenic, and/or myogenic
differentiation potential 34, 35. Since the mouse placenta is a potent hematopoietic territory it
is expected that this tissue will also yield hematopoietic supportive MSC lines and exhibit
similar differentiation potentials.
MSC lines have already been isolated from human placenta and amnionic and chorionic
fetal membranes (reviewed in 36). At the developmental stages tested, ranging from week 3
to term, human MSC lines express classical mesenchymal markers as well as markers of
pericytes, CD146 and NG2 22, 37, and after gestational week 6, they possess the typical
mesenchymal lineage potentials (osteogenic, adipogenic and/or endothelial) 22, 36-46. Also,
some of these placental MSC lines constitute a potent feeder layer for in vitro maintenance
and/or expansion of human umbilical cord blood CD34+ cells and progenitors 22, primate
and human embryonic stem (ES) cells 23, 47, 48, and long-term-culture-initiating cells 23.
Immunostaining of human placental sections localize such mesenchymal cell types within
this tissue. Moreover, localized expression of CD146 and NG2 in the perivasculature of the
placenta suggests that placenta mesenchymal cells are pericytes 22, 37. Interestingly, a MSC
line derived [ad1]from the maternal part of a gestation week 3 human placenta provided
potent in vitro maintenance and expansion of human umbilical cord blood CD34+ cells and
an 8-fold increase in immature hematopoietic progenitors compared to to the input number
in the sorted CD34+ cord blood population 22, suggesting that maternal cells contribute to
the early hematopoietic supportive microenvironment by promoting the growth of the
placenta as a highly vascular and hematopoietic territory. Thus, the hematopoietic inductive/
supportive microenvironment of the placenta could be unique as compared to the other
foetal and adult hematopoietic territories, and it most likely consists of the vascular
endothelial, mesenchymal and syncytiotrophoblast cells that develop in parallel in the villi.
The coordinated development of microenvironment within the labyrinth requires vessel
generation, invasion, branching morphogenesis and syncytiotrophoblast differentiation 4.
Genetic studies in mutant mice have identified a panel of genes important for some of these
processes 5. For example, the transcription factor encoded by Gcm1 is a pivotal molecule in
the initiation of morphogenesis and syncytiotrophoblast differentiation. The germline
deletion of Gcm1 (Glial cells missing 1) in mice is lethal at midgestation owing to a failure
to develop the placenta labyrinth layer 49. Originally identified in Drosophila, Gcm is
involved in macrophage-like cell development 50. In the mouse it is almost exclusively
expressed in the placenta 51. Similarly, deletion of Esx1, a homeobox gene, results in failure
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to develop the labyrinth layer 52. PPARγ is required for the invasion of foetal vessels into
the presumptive labyrinth at E9.5, as are the developmental factors such Wnt2 and EphB4/
ephrin B2 4. It will be interesting to determine how the placental hematopoietic
microenvironment and hematopoiesis are affected in these mouse models, and whether
hematopoiesis occurs normally in other hematopoietic sites.
Generator or storage tissue for hematopoietic cells?
The hematopoietic system originates in the mesodermal germ layer of the conceptus.
Histologic observation of yolk sac blood island anatomy linked the development of vascular
endothelial and hematopoietic cells 53, 54. These studies suggested a common mesodermal
precursor for these two lineages of cells, and the precursor cell was given the name
hemangioblast. Other histologic studies proposed that the precursors of hematopoietic cells
in the embryonic dorsal aorta are hemogenic endothelial cells, as clusters of hematopoietic
cells are closely associated with the ventral endothelium of the dorsal aorta at early stages of
development 13. Cell tracing 55, 56in mouse models in conjunction with vital imaging of
mouse ES cell hematopoietic differentiation cultures and in vitro cultured early posterior
primitive streak cells 57, 58show that hematopoietic cells transit through an endothelial cell
stage before taking on hematopoietic fate. In vivo real-time imaging of the intact
midgestational dorsal aorta shows the emergence of hematopoietic progenitor/stem cells
from endothelial cells lining this vessel 59. Because the vasculature and other cells of the
placenta originate from the allantoic mesoderm, which arises from the primitive streak at
early stages of development, the allantoic mesoderm is postulated to be hemogenic.
Indeed, the allantois of the developing chick can produce hematopoietic cells 11, 60. Blood-
island-like clusters of hematopoietic cells are found in the prevascularized allantois, and
upon engraftment into the coelom of host embryos, the cells arising from the donor allantois
contribute to adult blood. Results in mouse embryo grafting experiments examining this
question are less clear. After engraftment and a short culture period, donor allantoic cells
contribute to the endothelial lineage but only very rarely to a small number of erythroid
cells 61. More recently, others have found that the mouse prefusion allantois and chorion
tissues both possess intrinsic hematopoietic potential 62, 63; they give rise to clonogenic
haematopoietic progenitors following a 48-hour organ explant culture period 63. Moreover,
definitive hematopoietic markers such as Runx1 (a pivotal hematopoietic transcription
factor 64) and Ly6A GFP (HSC marker 65) are expressed in the early allantois and chorion,
indicating the hematopoietic potential 63. Thus, before it becomes vascularized, the early
stage placenta is intrinsically hemogenic.
At a slightly later developmental stage, the mouse placenta generates hematopoietic
progenitors. Embryos deficient for the Ncx1 gene 66 lack a heart beat and blood circulation,
which is normally established between the embryo body and the extraembryonic tissues at
E8.25. If in the absence of circulation a tissue such as the yolk sac, placenta or the body of
the embryo contains hematopoietic cells, then the hematopoietic cells must be generated
intrinsically 67. Indeed, erythro-myeloid and lymphoid progenitors are detected in the
Ncx1-/- embryo body, yolk sac and placenta 18, 67, indicating their intrinsic hemogenic/
hematopoietic capacity.
Because Ncx1-/- embryos die before E11, the time at which HSC activity is first detected in
the placenta, it is as yet uncertain whether the placenta can generate HSCs. Quantitative
studies, in which HSC numbers in each of the tissues of the conceptus was determined 68,
suggest that the aorta (the only tissue shown to autonomously generate HSCs) cannot
produce all of the HSCs that eventually are found in the foetal liver and the adult bone
marrow (tissues that harbour but do not generate HSCs) (Figure 2). In this regard, the
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midgestation mouse placenta contains an abundance of HSCs 16, 17, supporting the notion
that this highly vascularized tissue generates HSCs from hemogenic endothelium and/or that
it provides a unique supportive growth niche for expansion of aorta-derived HSCs.
Similarly, the human placenta might also autonomously generate HSCs and/or promote their
expansion to large numbers before they migrate to the bone marrow. Recent studies showing
the importance of mechanical stimuli provided by circulation in AGM HSC development 69
suggests that mechanical stimuli as well as hypoxia 70 could be important factors in
placental and HSC development.
The placenta in hematopoietic development
Hematopoiesis in the mouse and human conceptus progresses in wave-like stages (reviewed
in 13, 25). The three hemogenic/hematopoietic tissues, the yolk sac (YS), the AGM region
(and its precursor tissue the para-aortic splanchnopleura) and the chorio-allantoic placenta
are active at different but overlapping stages of development. They produce varying
repertoires and quantities of hematopoietic cells and support them in distinct
microenvironments. It is curious that eutherian mammals use the placenta as a hemogenic
and hematopoietic tissue, whereas other mammals and nonmammalian vertebrates develop a
fully functional hematopoietic system in the absence of a placenta. However, in these other
vertebrate embryos, it is possible that hematopoietic cells emerging in the allantois are
amplified elsewhere. In marsupials, the allantois is mainly avascular and does not fuse with
the chorion. Many variations in placental structure are seen in mammals. It is discoid in
mouse and man, and in species like the pig, horse and whale it is diffuse and distributed over
most of the uterus inner surface 4. Interestingly, the evolution of the placenta as a complex
organ has occurred multiple times, as found in the fish genus Poeciliopsis 71. Hence, is the
more fully developed placenta irrelevant as a hematopoietic tissue or does it play a special
role in blood development in mammals?
One notion is that the large size of the mammalian foetus and the extended length of the
gestational period might require a greater quantity of hematopoietic progenitors and HSCs
for foetal growth, and this can only be accomplished in an extra hematopoietic tissue such as
the placenta. Indeed, the placenta is large as compared to the size of the other hematopoietic
tissues of the embryo, and thus, it represents a significant space for producing, amplifiying
and/or harbouring hematopoietic cells.
Another idea concerning the functional relevance of the placenta comes from studies of
Runx1 haploinsufficient mouse embryos; in these mice, which have half a dose of the Runx1
transcription factor protein, the AGM region produces fewer HSCs 43, 72. However, Runx1
haploinsufficiency does not have negative effects on HSCs in the extraembryonic tissues
(yolk sac and placenta) or fetal liver, and instead results in a surprising increase in HSC
numbers in the placenta 43. Hence, the placenta appears to be more resistant to genetic/
physiologic changes, implicating it as a highly robust hematopoietic tissue in
nonhomeostatic conditions.
Additionally, the provision of growth factors such as interleukin 3 (IL-3) by the maternal
part of the placenta can stimulate the hematopoiesis 73. IL-3 is a potent HSC survival and
proliferation factor during embryonic development 43 and the IL-3 gene is a known direct
downstream transcriptional target of Runx1. Interestingly, human placenta MSCs produce
SCF (stem cell factor), Flt3 ligand, IL-6 and M-CSF (macrophage-colony stimulating
factor), among other hematopoietic factors 23. Thus, both maternal- and foetal-derived
factors may contribute to the growth of the placenta hematopoietic niche and the support of
hematopoietic cells.
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Overall, the human placenta plays an important and multifaceted role in the development
and growth of the foetus. Its structural complexity and its immense vascular network
containing large quantities of circulating blood cells and progenitors, make it a difficult
tissue to understand, particularly concerning its precise role in the development of the
mammalian hematopoietic system. The ongoing challenge is to determine whether the
placenta just contains reserve cohorts of hematopoietic progenitor and stem cells, or whether
these cohorts of cells are required for adult hematopoiesis and migrate to the bone marrow at
the end of fetal development before the time of delivery.
Concluding remarks
The discovery of HSCs in the human placenta throughout development and their localization
to the highly vascular compartment of this tissue opens new lines of inquiry with potential
medical implications (Box 1). As a new source of HSCs, the term human placenta as yet
yields only relatively small numbers. The present cell extraction procedures that include
dissection, enzymatic digestion with three enzymes (collagenase, dispase and pancreatin)
and mechanical dispersion yield about 10% of the total number of HSCs found in a unit of
umbilical cord blood 22, 74. Although placenta HSCs can be stored much like umbilical cord
blood HSCs, harvest efficiencies together with the cost- and labor-effectiveness must
improve before any potential clinical applications can be considered. In this regard, a more
easily isolatable source of HSCs with potential for regenerative medicine has recently been
discovered, the amniotic fluid 75.
Box 1
Outstanding Questions
Does the placenta have the ability to generate hematopoietic stem cells? The placenta
contains hematopoietic stem cells 22, but it is as yet undetermined whether the placenta
can intrinsically produce these potent, therapeutically important stem cells 18.
Does the placenta contain hemangioblasts and/or hemogenic endothelial cells? Results
from studies of the mouse chorion and allantois have shown that these tissues possess
intrinsic hematopoietic potential 62, 63. In the absence of circulation, the mouse placenta
intrinsically generates multipotent progenitors 18; however, it is as yet unknown whether
the vasculature of the labyrinth and/or the mesenchymal cells within the villi are
hemogenic.
How many hematopoietic stem cells does a human placenta contain? If placenta-derived
cells are to be contemplated for hematopoietic transplantation purposes, they must be at
least as abundant as those available in the umbilical cord blood. Improvements in
extraction procedures should optimize both quantitative yields and viability of these cells.
How robust are placenta HSCs in transplantation scenarios? Xenotransplants of human
placenta cells reveal the presence of multipotent, long-term engrafting HSCs. However, it
is uncertain whether placental HSCs are qualitatively as potent (in proliferation,
differentiation and self-renewal) as those from umbilical cord blood and adult bone
marrow.
Does the placenta contain a unique hematopoietic inductive/supportive
microenvironment? The placenta is an extraembryonic and transient tissue; it is uncertain
whether unique placental cell types and genetic programs regulate the development of
hematopoietic cells differently than in the other embryonic and adult hematopoietic
tissues.
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Importantly, knowledge from developmental studies demonstrating the hemogenic nature of
the early-stage chorio-allantoic placenta 18, 62, 63 offers a new and exciting challenge in the
field. Insights into the signals that drive hematopoietic cell generation from mesodermal
precursors, endothelial cells and the development of placenta labyrinth and villi could
provide new strategies for the production of hematopoietic cells from the numerous vascular
endothelial cells of the foetal part of this tissue. A recent study with early stage human
embryos has identified a marker ACE (angiotensin converting enzyme, CD143) recognized
by the BB9 antibody, on a subset of human mesoderm that establishes a population of
hemogenic endothelial cells within the fetus 76. The ACE-expressing cells possess
hematopoietic potential in long term cultures and in SCID mouse in vivo reconstitution
assays. Moreover, ACE-expressing cells isolated from human ES cells differentiated into
embryoid bodies are hemangioblastic-like angiohematopoietic cells. It will be interesting to
examine the human placenta for BB9 expression and if such cells are found to examine their
hemogenic potential. Characterization of the molecular program of ACE-expressing cells
should yield information on the genes involved in HSC specification, amplification and
maintenance.
Of future interest is the prospect of using this knowledge of the genetic program to induce
the differentiation of early populations of hemogenic cells to HSC fate, particularly if large
numbers of such cells can be isolated from the placenta. Alternatively, with the advancement
of the technology of reprogramming somatic cells to pluripotent stem cells, it may be
possible, with our complete knowledge of the pivotal factors involved in HSC generation to
obtain other patient-specific cells that can be reprogrammed into therapeutically potent
HSCs 77. In this regard, the human placenta, allantoic and chorionic foetal membranes 36
provide an abundant source of developmentally young somatic cells such as MSCs, that may
be stored, differentiated and/or reprogrammed for regenerative medicine.
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Glossary
Placenta extraembryonic tissue derived from the chorion and allantois
of the early stage mammalian conceptus.
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Allantois posterior outgrowth of the early stage embryo with
hematopoietic potential. It gives rise to the vessels in the
umbilical cord of mammals. In birds and reptiles, it is involved
in oxygen exchange and is a reservoir of nitrogenous waste.
Chorion membrane separating the fetus and mother that is formed by
the extraembryonic mesoderm and trophoblast.
Endosteal and
endothelial niches
specific anatomical locations/microenvironments within the
adult bone marrow that produce factors or provide important
cell-cell interactions for the maintenance, self-renewal and/or
differentiation of hematopoietic progenitors and stem cells.
The endosteal niche containing osteoblasts juxtaposed to the
bone. The endothelial niche is the vasculature within the bone
marrow.
Hematopoietic stem
cells
the rare cells existing within the bone marrow cavities of the
adult that contribute to the life-long production of all blood
cells of the hematopoietic system. These cells are long-lived,
self renewing and possess potential to produce all
hematopoietic cell lineages.
Hematopoietic
progenitor cells
intermediate cells within the adult hematopoietic cell
differentiation hierarchy. Having restricted differentiation
potential, they expand and differentiate to one or a few
hematopoietic lineages. They are generally short-lived and do
not self-renew.
Hemangioblastic cords In the early stage human placenta, mesodermal/mesenchymal
cells that are the precursors of vascular endothelial and
hematopoietic cells.
Labyrinth region of the placenta in which the trophoblast and its
associated fetal blood vasculature undergoes extensive
branching of the villi into a densely packed structure.
Pericytes a relatively undifferentiated cell type that surrounds blood
vessels. It possesses multilineage differentiation potential and
is thought to be the precursor of mesenchymal stem/stromal
cells (MSC).
Syncytiotrophoblasts the outer most cell type of the fetal placenta. They invade the
uterine wall and provide the large surface area for exchange of
oxygen, nutrients and waste between the fetus and mother.
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Figure 1.
Placenta structure at different times in development (a) Early stages of chorio-allantoic
placenta formation. The placenta is formed from the fusion of the allantois with the chorion.
The allantois is a mesodermal outgrowth emanating from the posterior primitive streak. It
elongates and upon contact with the chorionic mesoderm gives rise to the labyrinth of the
placenta. (b) Mouse placenta structure. The placenta consists of the several cell types and
layers. The side of the placenta facing the fetus is the labyrinth. It consists of a vascular
network contiguous with the umbilical cord. The network of vessels in the labyrinth form
branched villous structures that are surrounded by mesenchymal stromal and
syncytiotrophoblast cells. The maternal vessels run through the spongiotrophoblast region
(facing the mother) to open into the intervillous space (white area) where physiologic
exchange between mother and fetus occurs.
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Figure 2.
Hematopoiesis in the mouse embryo and placenta. (a) Sites of hematopoiesis in the
midgestion (E10.5) mouse conceptus. Extraembryonic hematopoietic territories include the
chorio-allantoic placenta and the yolk sac. Hematopoietic territories within the embryo body
are the aorta (hematopoietic part of the AGM region) and the liver. The yolk sac, placenta
and AGM are sites of de novo hematopoietic cell generation, whereas the liver is colonized
by exogenously generated hematopoietic cells. Temporal appearance of hematopoietic cells
in different tissues (from E 7.5 until birth).
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Figure 3.
Hematopoiesis in the human conceptus and placenta Temporal appearance of hematopoietic
cells in the yolk sac (YS), AGM region, liver and placenta of the human conceptus from
gestational weeks in the first and second trimesters through term. BFU-E (burst forming
unit-erythroid) represents the earliest erythroid progenitors. Multipotent progenitors can
produce erythroid and myeloid lineage cells.
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